Tesla, Costco, Marvell, Ulta Beauty, PDS Biotechnology: Why These 5 Stocks Are Drawing Investor Attention

Zinger Key Points
  • Costco reported net sales of $52.6 billion for the third quarter, up 1.9% year-over-year.
  • Marvell reported first quarter net revenue at $1.322 billion, which came ahead of a $1.3 billion estimate.
  • Ulta Beauty reported first quarter revenue of $2.63 billion that beat an estimate of $2.62 billion.

The Nasdaq Composite and the S&P 500 ended in the green on Thursday after NVIDIA Corporation's NVDA upbeat forecast led investors to pile up AI-related stocks despite the debt ceiling crisis continuing without a resolution. Shares of the chip-maker closed 24.37% higher on Thursday. Meanwhile, the following are the five stocks that are drawing investors' attention:

1. Tesla Inc TSLA: Shares of Tesla closed 0.86% higher on Thursday. German officials gave serious indications of possible data protection violations by the EV-maker, reported Reuters citing the Handelsblatt newspaper.

Also Read: Everything You Need To Know About Tesla Stock

2. Costco Wholesale Corporation COST: Shares of the company closed 0.79% higher on Thursday. Costco reported net sales of $52.6 billion for the third quarter, up 1.9% year-over-year. Membership revenue stood at $1 billion in the third quarter, compared to $984 million in the year-ago period.

3. Marvell Technology Inc MRVL: Shares of the company closed 7.59% higher on Thursday and gained another 16.74% in extended trading. Marvell reported first-quarter net revenue at $1.322 billion, which came ahead of a $1.3 billion estimate, according to Benzinga Pro. The company expects second-quarter net revenue within a 5% range of $1.330 billion.

4. Ulta Beauty Inc ULTA: Shares of the company lost 8.84% in extended trading on Thursday. The company reported first-quarter revenue of $2.63 billion which beat an estimate of $2.62 billion. Ulta Beauty raised its revenue outlook from $10.95 billion to $11.05 billion to a range of $11 billion to $11.1 billion. This compared with an estimate of $11.12 billion.

5. PDS Biotechnology Corp PDSB: Shares of the company closed 6.99% lower on Thursday but gained over 31% in extended trading. PDS Biotechnology announced promising interim data from the VERSATILE-002 Phase 2 clinical trial.

Read Next: Sony Unveils PlayStation Handheld Device And Gaming Earbuds At PlayStation Showcase

Market News and Data brought to you by Benzinga APIs
Posted In: EquitiesNewsMarketsArtificial Inteliigenceelectric vehiclesTrending stocksWall Street
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...